ESR1 and breast neoplasm: This worse prognostic feature of high SHOX2 expression also corresponded with ER negative (ER−) breast tumors having overall higher SHOX2 expression than ER positive (ER+) breast tumors (p < 0.0001) (Fig. 1b).